![John Hunter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
John Hunter formerly worked at XOMA Royalty Corp., as Senior Director, Compugen Ltd., as Chief Scientific Officer, Compugen, Inc. (United States), as Vice President-Antibody R&D, Keyhole Therapeutics, Inc., as Chief Executive & Scientific Officer, and FibroGen, Inc., as Chief Scientific Officer from 2021 to 2024.
Dr. Hunter received his undergraduate degree from Hartwick College and doctorate degree from The University of California, San Francisco.
Ultime notizie su John Hunter
Precedenti posizioni note di John Hunter
| Società | Posizione | Fine |
|---|---|---|
| FIBROGEN, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2024 |
| XOMA ROYALTY CORPORATION | Direttore/Membro del Consiglio | - |
Keyhole Therapeutics, Inc. | Amministratore Delegato | - |
| COMPUGEN LTD. | Direttore Tecnico/Scientifico/R&S | - |
Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Formazione di John Hunter
Hartwick College | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| XOMA ROYALTY CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Compugen, Inc. (United States) | |
Keyhole Therapeutics, Inc. |
- Borsa valori
- Insiders
- John Hunter
